TickerGuard
Buy Day today: Neutral (53) Mixed market breadth · no major macro event

Tempus AI, Inc. (TEM)

Healthcare Health Information Services
43.90 $
-0.9% vs. previous close
Closing price · As of: 31. Jul 2026
🔔 Watch stock

Stock Watch

Stock Watch will tell you what changes at Tempus AI, Inc..

Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.

Appears in These Scanners

This stock currently matches 1 of our scanner strategies — each hit links to the scanner.

Risk & Weakness

Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners

Trading Day

Previous Close
44.30$
Open
46.20$
Day High
46.30$
Day Low
42.30$
Volume
7,266,000shares

Key levels of the most recently completed trading day — not a live quote.

52-Week Range

52-Week Low 52-Week High
41.60 $ 103.30 $
07/29/2026 10/08/2025

Current price 43.90 $ — 4% of the range above the low.

Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.

Basics

Market Cap
7.8$B
Shares Outstanding
175Mio.
Float
68.2%
Beta
3.5

Performance

Perf. 1M
13.70%
Perf. 3M
36.80%
Perf. 6M
-9.30%
YTD Performance (%)
-17.70%
52-Week-High Distance
-47.4%
Perf. 1Y
-22.48%
Perf. 5Y
29.04%
Perf. Since Inception
8.99%

Technical Indicators

MA 38 Days
51.80$
MA 50 Days
51.00$
MA 200 Days
59.40$
RSI (14)
38.0
Volatility 30 Days
71.2%
Volatility 250 Days
65.9%

Calculated from the price history · as of 08/03/2026

Valuation

P/E
Forward P/E
0.0
PEG
P/B
18.9
P/S
5.4
EV/EBITDA
0.0
Price/FCF

Profitability

Gross Margin
64.0%
EBIT Margin
-24.3%
Net Margin
-17.8%
Return on Equity
-81.6%
Return on Assets
-8.8%

Balance Sheet & Safety

Equity Ratio
19.5%
negative equity
Debt/Equity
-24.5
Altman Z″
1.15
Piotroski
3 out of 9

Growth

Sales Growth Last Quarter
36.10%
EPS Growth Last Quarter
0.00%
Sales Growth (Year)
83.41%
Forward Sales Growth
22.17%
Forward EPS Growth
71.90%

Dividend

This stock currently pays no dividend.

Quality & Screener

Stage
4
RS Rating
15
EPS Rating
42
Piotroski
3 out of 9
Fundamental Rating
B (65 out of 100)
Altman Z″
1.15

AI Rating

Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built

Growth Score

6 of 10 Solid growth

Ten checks against the annual reports — each one passed counts a point.

  • Revenue grows by more than 15% a year over three years 58.3% passed
  • More than 10% revenue growth is expected for the coming year 22.2% passed
  • Share count grows by less than 3% a year 0.9% passed
  • Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 64.6% passed
  • Gross margin at 40% or higher and without meaningful erosion 69.6% passed
  • Goodwill from acquisitions does not grow faster than revenue 20.7% failed
  • Net debt below twice EBITDA failed
  • Operating cash flow covers the profits of the last three years 543 m failed
  • Return on capital at 15% or higher, or up versus two years ago -12.5% failed
  • Insiders hold at least 10% or are net buyers 37.1% passed

A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail

Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.

Analysts & Price Target

Current Price 43.90 $
Price Target (average) 64.93 $

The price target sits 47.9% above the current price.

Consensus
Sell
Analyst Ratings
12
Distribution of Recommendations
Strong Buy 4
Buy 2
Hold 6
Sell 0
Strong Sell 0

Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.

Estimates by Fiscal Year

Estimates by Fiscal Year
Fiscal Year EPS Estimate ($) EPS Range ($) Revenue Estimate ($M) Expected Growth Analysts
12/31/2026 -0.30 -0.50 – -0.09 1,596 50.4% 12
12/31/2027 -0.05 -0.45 – 0.54 1,967 84.0% 12

Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.

Next Reporting Date

14. Aug 2026

Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.

Revenue & Profit

Cash Flow

Balance Sheet

Margins

Per Share

Click the chart or tab into it, then use ← and → to step through the periods.

None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.

These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.

The figures could not be loaded right now.

Sales Per Quarter ($M)
2024: Q4 · 200.7 $M Q4 2025: Q1 · 255.7 $M Q1 2025: Q2 · 314.6 $M Q2 2025: Q3 · 334.2 $M Q3 2025: Q4 · 367.2 $M Q4 2026: Q1 · 348.1 $M Q1 2026: Q2 · 382.5 $M Q2

Source: fundamental data

Compare with other stocks →

Quarterly Figures

Quarterly Figures
Quarter EPS (Earnings Per Share) EPS YoY (%) Sales ($M) Sales YoY (%) Net Margin (%) OCF ($M) FCF ($M)
2024: Q4 -0.08 201 35.80 -6.50 -39 -47
2025: Q1 -0.40 256 75.40 -26.60 -106 -109
2025: Q2 -0.25 315 89.60 -13.60 44 35
2025: Q3 -0.46 334 84.70 -23.90 -120 -127
2025: Q4 -0.31 367 83.00 -14.80 -37 -43
2026: Q1 -0.70 348 36.10 -36.20 -73 -82
2026: Q2 0.03 112.00 383 21.60 1.50 -8 -14
What Do These Terms Mean?
EPS (Earnings Per Share):
Quarterly profit divided by the total share count — how much of the profit works out to a single share.
YoY (Year over Year):
Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
Sales:
All revenue for the quarter, before any costs are deducted — the top line of the income statement.
Net Margin:
What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
OCF (Operating Cash Flow):
The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
FCF (Free Cash Flow):
Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.

Annual Figures

Annual Figures
Fiscal Year Revenue ($M) EBIT ($M) Net Income ($M) EPS ($) Operating Cash Flow ($M) Equity ($M) Total Assets ($M)
2019 62 -120 -115 -0.72 -117 -254 370
2020 188 -193 -210 -1.24 -207 -513 752
2021 258 -244 -259 -1.53 -212 -807 531
2022 321 -265 -290 -1.71 -168 -1,129 631
2023 532 -196 -214 -1.39 -214 -1,382 564
2024 693 -691 -706 -4.35 -189 56 926
2025 1,272 -239 -245 -1.41 -218 491 2,275

Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.

About the Company

Tempus AI, Inc. ist als Gesundheitstechnologieunternehmen in den USA tätig.

CEO Insider Trades (12 Mo.)selling own stock
Employees3,800
HeadquartersChicago, IL
Address600 West Chicago Avenue, 60654 Chicago, United States
Phone800 976 5448
Websitetempus.com
IPO Date14. Jun 2024
ISINUS88023B1035

Management

Management
Name Title Birth Year
Eric P. Lefkofsky J.D. Co-Founder, CEO, President & Chairman 1970
James Rogers Chief Financial Officer 1987
Erik Phelps Executive VP and Chief Administrative & Legal Officer 1971
Ryan Fukushima Chief Executive Officer of Data & Apps 1986
Ryan M. Bartolucci CPA Chief Accounting Officer 1982
Shane Colley Chief Technology Officer
Kate A. Sasser Ph.D. Chief Scientific Officer 1978
Elizabeth Krutoholow Vice President of Investor Relations & Competitive Intelligence
Christina Antoniou Senior VP & Head of Corporate Development
Stacey Kraft Chief People Officer

Executives per the latest required filings; titles kept in their original language. Source: fundamental data.

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
29. Jul 2026 Rogers James William Chief Financial Officer Other 40,000 0.00
29. Jul 2026 Polovin Andrew EVP, Chief Legal Officer Other 40,000 0.00
28. Jul 2026 Lefkofsky Eric P CEO and Chairman Sell 5,324 42.95 228,666
28. Jul 2026 Lefkofsky Eric P CEO and Chairman Sell 26,875 42.36 1,138,425
28. Jul 2026 Lefkofsky Eric P CEO and Chairman Sell 17,801 41.34 735,893
28. Jul 2026 Lefkofsky Eric P CEO and Chairman Sell 798 42.95 34,274
28. Jul 2026 Lefkofsky Eric P CEO and Chairman Sell 4,031 42.36 170,753
28. Jul 2026 Lefkofsky Eric P CEO and Chairman Sell 2,671 41.34 110,419
28. Jul 2026 Lefkofsky Eric P CEO and Chairman Sell 14,374 42.95 617,363
28. Jul 2026 Lefkofsky Eric P CEO and Chairman Sell 72,560 42.36 3,073,642

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.

View all insider transactions →

Chart

Interactive price chart (TradingView).

Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?